A new Nature Communications study suggests that insulin resistance tracks with higher risk for 12 cancer types. An international research team applied an unusual approach — instead of measuring insulin resistance directly, they developed an algorithmic proxy, opening the door to population-scale risk analyses. Here’s why that matters.
